The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1083
ISSUE 1083
July 24, 2000
Issue 1083
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Pantroprazole (Protonix)
July 24, 2000 (Issue: 1083)
Pantoprazole, the fourth benzimidazole proton pump inhibitor to become available in the United States, has been marketed for short-term oral treatment of erosive gastroesophageal reflux disease (GERD).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.